ScalpingX

📊 $PENGU – Liquidation Map (30 days) – Index ~0.0097
🔎 Quick read
• Long liquidation clusters below are concentrated around 0.00914–0.00887 → 0.00887–0.00857, with a thicker pocket at 0.00842–0.00812, and deeper liquidity sitting at 0.00797–0.00767 → 0.00749–0.00734.
• Short liquidation clusters above begin around 0.00998–0.01028, then become denser at 0.01028–0.01049, with a farther cluster at 0.01067–0.01088.
• The thin zone near price is around 0.00971–0.00998, suggesting price is sitting in a relatively light liquidity pocket; once it leaves this base, the move could accelerate more quic

China blocks Meta’s Manus deal, reigniting geopolitical risk in the global AI race
📌 China has ordered the cancellation of Meta’s acquisition of AI startup Manus, citing national security and control over strategic technology. The news emerged on April 27 and quickly drew attention, as Manus is seen as one of the notable AI agent startups with Chinese roots.
🔎 The key point is that Manus is registered in Singapore, yet Beijing still views it as a sensitive technology asset. This suggests that moving a legal entity offshore may no longer be enough to reduce regulatory risk if the core technol

$TRUMP - Mcap 593.36M$ - 63%/ 1.1M votes Bullish
SC02 M5 - pending Short order. Entry lies within HVN + not affected by any weak zone, the current resistance zone is approximately 0.58% wide. The downtrend has lasted for 17 hours 35 minutes, with the largest recorded price decline at 4.49%. If price breaks above this resistance zone, there is a high probability that the trend will reverse to the upside.

$XCN - Mcap 250.19M$ - 86%/ 127K votes Bullish
SC02 M5 - pending Long order. Entry lies within LVN + not affected by any weak zone, the current support zone is approximately 8.53% wide. The uptrend has lasted for 7 hours 35 minutes, with the largest recorded price increase at 57.89%. If price loses this support zone, there is a high probability that the trend will reverse to the downside.

Sun Pharma launches India’s largest outbound pharma deal with Organon
📌 Sun Pharma announced an all-cash agreement to acquire Organon for $11.75 billion, or $14 per share, marking a major international move for India’s pharmaceutical sector.
💊 Organon was spun off from Merck in 2021 and owns more than 70 products across around 140 countries, with exposure to women’s health, general medicines, and biosimilars.
📈 After the deal, Sun Pharma is expected to reach around $12.4 billion in combined revenue, enter the top 25 global pharmaceutical companies, and lift innovative medicines to 27% of to

$MYX - Mcap 69.11M$ - 57%/ 37K votes Bullish
SC02 M5 - pending Short order. Entry lies within LVN + not affected by any weak zone, the current resistance zone is approximately 1.34% wide. The downtrend has lasted for 10 hours 5 minutes, with the largest recorded price decline at 7.20%. If price breaks above this resistance zone, there is a high probability that the trend will reverse to the upside.